These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38901198)

  • 1. Emerging insights into Lipocalin-2: Unraveling its role in Parkinson's Disease.
    Qiu R; Cai Y; Su Y; Fan K; Sun Z; Zhang Y
    Biomed Pharmacother; 2024 Aug; 177():116947. PubMed ID: 38901198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenic Upregulation of Glial Lipocalin-2 in the Parkinsonian Dopaminergic System.
    Kim BW; Jeong KH; Kim JH; Jin M; Kim JH; Lee MG; Choi DK; Won SY; McLean C; Jeon MT; Lee HW; Kim SR; Suk K
    J Neurosci; 2016 May; 36(20):5608-22. PubMed ID: 27194339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipocalin 2 regulates iron homeostasis, neuroinflammation, and insulin resistance in the brains of patients with dementia: Evidence from the current literature.
    Lim D; Jeong JH; Song J
    CNS Neurosci Ther; 2021 Aug; 27(8):883-894. PubMed ID: 33945675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased plasma lipocalin-2 levels are associated with nonmotor symptoms and neuroimaging features in patients with Parkinson's disease.
    Fan Y; Li X; Ma J; Yang D; Liang K; Shen Y; Wei W; Dong L; Liu C; She Z; Qi X; Shi X; Gu Q; Zheng J; Li D
    J Neurosci Res; 2024 Feb; 102(2):e25303. PubMed ID: 38361408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipocalin 2 contributes to brain iron dysregulation but does not affect cognition, plaque load, and glial activation in the J20 Alzheimer mouse model.
    Dekens DW; Naudé PJW; Keijser JN; Boerema AS; De Deyn PP; Eisel ULM
    J Neuroinflammation; 2018 Nov; 15(1):330. PubMed ID: 30501637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipocalin 2: An Emerging Player in Iron Homeostasis and Inflammation.
    Xiao X; Yeoh BS; Vijay-Kumar M
    Annu Rev Nutr; 2017 Aug; 37():103-130. PubMed ID: 28628361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of lipocalin 2 in stroke.
    Zhao RY; Wei PJ; Sun X; Zhang DH; He QY; Liu J; Chang JL; Yang Y; Guo ZN
    Neurobiol Dis; 2023 Apr; 179():106044. PubMed ID: 36804285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipocalin-2: a therapeutic target to overcome neurodegenerative diseases by regulating reactive astrogliosis.
    Jung BK; Ryu KY
    Exp Mol Med; 2023 Oct; 55(10):2138-2146. PubMed ID: 37779143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipocalin 2 attenuates iron-related oxidative stress and prolongs the survival of ovarian clear cell carcinoma cells by up-regulating the CD44 variant.
    Yamada Y; Miyamoto T; Kashima H; Kobara H; Asaka R; Ando H; Higuchi S; Ida K; Shiozawa T
    Free Radic Res; 2016; 50(4):414-25. PubMed ID: 26729415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive review of lipocalin 2-mediated effects in lung inflammation.
    Guardado S; Ojeda-Juárez D; Kaul M; Nordgren TM
    Am J Physiol Lung Cell Mol Physiol; 2021 Oct; 321(4):L726-L733. PubMed ID: 34468208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of lipocalin-2 in patients with Parkinson's disease.
    Xiong M; Qian Q; Liang X; Wei YD
    Neurol Sci; 2022 Mar; 43(3):1755-1759. PubMed ID: 34455500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of Toll-like receptors and neuroinflammation in Parkinson's disease.
    Heidari A; Yazdanpanah N; Rezaei N
    J Neuroinflammation; 2022 Jun; 19(1):135. PubMed ID: 35668422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mild Oxidative Stress Induced by Sodium Arsenite Reduces Lipocalin-2 Expression Levels in Cortical Glial Cells.
    Cho YJ; Park SH; Ryu KY
    Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron transport in Parkinson's disease.
    Hirsch EC
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S209-11. PubMed ID: 20082992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired iron homeostasis in Parkinson's disease.
    Double KL; Gerlach M; Youdim MB; Riederer P
    J Neural Transm Suppl; 2000; (60):37-58. PubMed ID: 11205155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interplay between neuroinflammatory pathways and Parkinson's disease.
    Eser P; Kocabicak E; Bekar A; Temel Y
    Exp Neurol; 2024 Feb; 372():114644. PubMed ID: 38061555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipocalin-2 as a mediator of neuroimmune communication.
    Afridi R; Kim JH; Bhusal A; Lee WH; Suk K
    J Leukoc Biol; 2024 Jul; 116(2):357-368. PubMed ID: 38149462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipocalin-2 Is a Key Regulator of Neuroinflammation in Secondary Traumatic and Ischemic Brain Injury.
    Kim JH; Kang RJ; Hyeon SJ; Ryu H; Joo H; Bu Y; Kim JH; Suk K
    Neurotherapeutics; 2023 Apr; 20(3):803-821. PubMed ID: 36508119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced secretion of LCN2 (lipocalin 2) from reactive astrocytes through autophagic and proteasomal regulation alleviates inflammatory stress and neuronal damage.
    Jung BK; Park Y; Yoon B; Bae JS; Han SW; Heo JE; Kim DE; Ryu KY
    Autophagy; 2023 Aug; 19(8):2296-2317. PubMed ID: 36781380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combating Parkinson's disease with plant-derived polyphenols: Targeting oxidative stress and neuroinflammation.
    Gahtani RM; Shoaib S; Hani U; Jayachithra R; Alomary MN; Chauhan W; Jahan R; Tufail S; Ansari MA
    Neurochem Int; 2024 Sep; 178():105798. PubMed ID: 38950626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.